Pure Biologics S.A. (WSE: PUR)
Poland
· Delayed Price · Currency is PLN 20.20
-0.60 (-2.88%)
Sep 27, 2024, 5:04 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 74.59 million as of September 30, 2024. Its market cap has increased by 63.44% in one year.
Market Cap
74.59M
Enterprise Value
82.56M
Revenue
69.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
20.20
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 74.59M, an increase of 177.83%. That is a compound annual growth rate of 19.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 17.90B |
| NEUCA S.A. | 3.76B |
| Sopharma AD | 2.14B |
| Synektik Spólka Akcyjna | 1.62B |
| Celon Pharma S.A. | 1.47B |
| Ryvu Therapeutics S.A. | 1.21B |
| Voxel S.A. | 1.13B |
| Selvita S.A. | 1.04B |